用经支气管镜单向活瓣置入肺减容术治疗COPD的研究进展  

Progress in the treatment of COPD by transbronchoscopic one-way valve implantation

作　　者：周茂旗 李先华[2] 张永[2] 王宪刚[2] 谢秀芳[2] ZHOU Maoqi;LI Xianhua;ZHANG Yong;WANG Xiangang;XIE Xiufang(Chengdu Medical College,Chengdu Sichuan 610500;Neijiang First People's Hospital,Neijiang Sichuan 641000)

机构地区：[1]成都医学院,四川成都610500 [2]内江市第一人民医院,四川内江641000

出　　处：《当代医药论丛》2021年第20期16-18,共3页

基　　金：四川省卫生健康委重点研究项目(17ZD003)。

摘　　要：慢性阻塞性肺疾病(COPD)是一种常见的慢性疾病。此病患者的主要临床表现为慢性支气管炎、肺气肿、持续性呼吸气流受限、肺功能进行性减退等,其生活质量可受到严重的影响。肺气肿是COPD患者最主要的病理改变之一。近年来,经支气管镜单向活瓣(FBV)置入肺减容术在治疗重度肺气肿方面得到了广泛的应用。本文就经支气管镜FBV置入肺减容术的临床应用情况作一综述。Chronic obstructive pulmonary disease(COPD)is a common chronic disease.The main clinical manifestations of patients with this disease are chronic bronchitis,emphysema,persistent respiratory airflow restriction,progressive decline of lung function,etc.,and their quality of life can be seriously affected.Emphysema is one of the most important pathological changes in COPD patients.In recent years,bronchoscopic one-way valve(EBV)implantation has been widely used in the treatment of severe emphysema.This article reviews the clinical application of bronchoscopic EBV implantation for lung volume reduction.

关 键 词：单向活瓣 肺减容术 慢性阻塞性肺疾病 肺气肿 

分 类 号：R563[医药卫生—呼吸系统]